Purple Biotech Ltd.
PPBT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614744
No open-market purchases or sales by Purple Biotech Ltd. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $141.0K in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Purple Biotech Ltd. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- +1 vs. Q2 2023
- Shares held
- 246.3K
- −31.2K (−11.3%) vs. Q2 2023
- Total value
- $275.9K
- −$112.4K (−28.9%) vs. Q2 2023
- New holders
- 2
- 4 more added
- Sold out
- 1
- 2 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PPBT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $141.0K |
| Q1 2026 | 15 | $305.6K |
| Q4 2025 | 19 | $513.2K |
| Q3 2025 | 16 | $75.9K |
| Q2 2025 | 14 | $133.7K |
| Q1 2025 | 9 | $134.3K |
| Q4 2024 | 14 | $377.9K |
| Q3 2024 | 11 | $946.1K |
| Q2 2024 | 21 | $775.9K |
| Q1 2024 | 21 | $1.77M |
| Q4 2023 | 20 | $1.90M |
| Q3 2023 | 18 | $275.9K |
| Q2 2023 | 17 | $388.3K |
| Q1 2023 | 16 | $224.2K |
| Q4 2022 | 15 | $238.6K |
| Q3 2022 | 11 | $224.0K |
| Q2 2022 | 14 | $310.2K |
| Q1 2022 | 14 | $1.77M |
| Q4 2021 | 13 | $4.09M |
| Q3 2021 | 12 | $5.27M |
| Q2 2021 | 13 | $3.72M |
| Q1 2021 | 15 | $2.40M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Purple Biotech Ltd.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Kingswood Wealth Advisors, LLC | 130,650 | $139.8K | 0.02% | +2,700+2.1% | Added |
| Morgan Stanley | 30,400 | $36.2K | 0.00% | +768+2.6% | Added |
| Venture Visionary Partners LLC | 14,562 | $17.3K | 0.00% | +844+6.2% | Added |
| Citadel Advisors LLC | 13,925 | $16.0K | 0.00% | −32,019−69.7% | Reduced |
| Wealth Advisors of Iowa, LLC | 13,270 | $15.8K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 12,666 | $14.6K | 0.00% | 00.0% | Unchanged |
| Raymond James & Associates | 11,000 | $13.1K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 7,773 | $8.00K | 0.00% | −1,385−15.1% | Reduced |
| TD Waterhouse Canada Inc. | 4,000 | $6.02K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 3,382 | $3.89K | 0.00% | +12+0.4% | Added |
| UBS Group AG | 1,867 | $2.22K | 0.00% | +1,867 | New |
| JPMorgan Chase & Co | 1,392 | $1.60K | 0.00% | +1,392 | New |
| Rhumbline Advisers | 555 | $638 | 0.00% | 00.0% | Unchanged |
| North Star Investment Management Corp. | 300 | $357 | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 336 | $333 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 50 | $60 | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 22 | $26 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 108 | $0 | 0.00% | 00.0% | Unchanged |
| Fiduciary Alliance LLC | 0 | $0 | 0.00% | −5,410−100.0% | Sold out |